Yıl: 2019 Cilt: 3 Sayı: 3 Sayfa Aralığı: 214 - 218 Metin Dili: İngilizce DOI: 10.14744/ejmi.2019.54835 İndeks Tarihi: 11-11-2020

Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer

Öz:
Objectives: The aim of our study is to identify the frequency and the types of immediate hypersensitivity reactionsthat might be encountered during chemotherapy usage as well as which chemotherapeutics carry more risk of causing immediate hypersensitiviy reactions, to make the expactations of the units that perform chemotherapies moreconcrete for at least immediate hypersensitivity reactions and the precautions to be taken.Methods: Sixty one patients with cancer who were hospitalised and treated in the pediatric oncology clinic. Thenumber of total chemotherapeutic drug dosage, the number of total dosage for each chemotherapeutic drug, thenumber of total hypersensitivity reactions, the number of reactions against each chemotherapeutic agent,the frequency of common hypersensitivity reaction and the frequency of hypersensitivity reaction for each chemotherapeutic agent were calculated.A total of 61 patients were followed. During the study period, 9 of 1992 chemotherapeutic dosages have beendetermined to cause immediate hypersensitivity reactions. Of the 61 patients followed during the study with thediagnosis of cancer, 8 developed hypersensitivity reaction.Results: It has been determined that the frequency of immediate hypersensitivity reactions against chemotherapeutic drugs was quite low and severe, life-threatening type anaphylactic reactions were not present.Conclusion: We found in the study group that the frequency of immediate hypersensitivity reactions to chemotherapeutic drugs was very low and no life-threatening severe anaphylactic reactions were found.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • 1. MJ Torres, M Blanca, J Fernandez, A Romano, A de Weck, W Aberer, K Brockow, WJ Pichler, P Demolyfor ENDA and the EAACI interest group on drug hyper sensitivity. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003;58:961 –72. [CrossRef]
  • 2. Syrigou E, Makrilia N, Koti I, Saif MW and Syrigos KN. Hypersensitivity reactions to antineoplastic agents: an overview. Anti-Cancer Drugs 2009;20:1 –6. [CrossRef]
  • 3. Gruchalla RS. Drug allergy. J. Allergy Clin Immunol 2003;111:548–59. [CrossRef]
  • 4. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005;5:309–16.
  • 5. Gonzales ID, Saez SR, Rodilla EM, Yges y EL, Toledano FL. Hypersensitivity reactions to chemotherapy drugs. Alergol Immunol Clin 2000;15:161 –81.
  • 6. Goldberg A, Altaras MM, Mekori YA, Beyth Y, Confio-Cohen R. Anaphylaxis to cisplatin: diagnosis and value of pretreatment in the prevention of recurrent allergic reactions. Ann Allergy 1994;73:271 –2.
  • 7. Dellinger CT, Maile TD. Comparison of anaphylactic reactions to asparaginase derived from Escherichiacoli and from Erwinia cultures. Cancer 1976;38:1843–6. [CrossRef]
  • 8. Harris RE, McCallister JA, Provisor DS, Weetman RM, Baehner RL. Methotrexate/L-asparaginase combination chemotherapy for patients with acute leukemia in relapse: a study of 36 children. Cancer 1980;46:2004–8. [CrossRef]
  • 9. Ewans WE, Tsiatis A, Rivera G, Murphy SB, Dahl GV, Denison M, et al. Anaphylactoid reactions to Escherichiacoli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer1982;49:1378–83. [CrossRef]
  • 10. Kellie SJ, Crist WM, Pui CH, Crone ME, Fairclough DL, Romdan JH, et al. Hypersensitivity reactions to epipodophyllotoxins in children with acutely myoblastic leukemia. Cancer 1991;67:1070–5. [CrossRef]
  • 11. Alberts D, Garcia D. Safety aspects of pegylated liposomal doxorubicin in patients with cancer. Drugs 1997;54:30–5.
  • 12. Dubinski M, Feldman E, Abreu M. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine. Am J Gastroenterol 2003;98:1058–63.
  • 13. Lam M. The need for routine Bleomycin test dosing in the 21st century. Ann Pharnacother 2005;39:1897–902. [CrossRef]
APA ÖZTÜRK O, ORHAN F (2019). Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. , 214 - 218. 10.14744/ejmi.2019.54835
Chicago ÖZTÜRK OSMAN,ORHAN FAZIL Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. (2019): 214 - 218. 10.14744/ejmi.2019.54835
MLA ÖZTÜRK OSMAN,ORHAN FAZIL Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. , 2019, ss.214 - 218. 10.14744/ejmi.2019.54835
AMA ÖZTÜRK O,ORHAN F Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. . 2019; 214 - 218. 10.14744/ejmi.2019.54835
Vancouver ÖZTÜRK O,ORHAN F Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. . 2019; 214 - 218. 10.14744/ejmi.2019.54835
IEEE ÖZTÜRK O,ORHAN F "Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer." , ss.214 - 218, 2019. 10.14744/ejmi.2019.54835
ISNAD ÖZTÜRK, OSMAN - ORHAN, FAZIL. "Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer". (2019), 214-218. https://doi.org/10.14744/ejmi.2019.54835
APA ÖZTÜRK O, ORHAN F (2019). Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. Eurasian Journal of Medical Investigation, 3(3), 214 - 218. 10.14744/ejmi.2019.54835
Chicago ÖZTÜRK OSMAN,ORHAN FAZIL Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. Eurasian Journal of Medical Investigation 3, no.3 (2019): 214 - 218. 10.14744/ejmi.2019.54835
MLA ÖZTÜRK OSMAN,ORHAN FAZIL Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. Eurasian Journal of Medical Investigation, vol.3, no.3, 2019, ss.214 - 218. 10.14744/ejmi.2019.54835
AMA ÖZTÜRK O,ORHAN F Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. Eurasian Journal of Medical Investigation. 2019; 3(3): 214 - 218. 10.14744/ejmi.2019.54835
Vancouver ÖZTÜRK O,ORHAN F Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer. Eurasian Journal of Medical Investigation. 2019; 3(3): 214 - 218. 10.14744/ejmi.2019.54835
IEEE ÖZTÜRK O,ORHAN F "Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer." Eurasian Journal of Medical Investigation, 3, ss.214 - 218, 2019. 10.14744/ejmi.2019.54835
ISNAD ÖZTÜRK, OSMAN - ORHAN, FAZIL. "Frequency of Hypersensitivity Reactions to Chemotherapeutic Agents in Children with Cancer". Eurasian Journal of Medical Investigation 3/3 (2019), 214-218. https://doi.org/10.14744/ejmi.2019.54835